Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

AdaptIV Infusion Opens State-Of-The-Art IV Infusion Clinic in Sugar Land, TX, Offering Patient-Focused Specialty Medication Treatments


News provided by

AdaptIV Infusion

Jul 26, 2023, 13:00 ET

Share this article

Share toX

Share this article

Share toX

AdaptIV Infusion, Sugar Land TX
AdaptIV Infusion, Sugar Land TX

AdaptIV Infusion seeks to transform the infusion therapy patient experience with new Sugar Land clinic specializing in treatments for autoimmune disorders and complex chronic conditions, as well as health and wellness therapies for Greater Houston residents.

SUGAR LAND, Texas, July 26, 2023 /PRNewswire-PRWeb/ -- AdaptIV Infusion announces the opening of its Sugar Land, TX infusion clinic. Conveniently located near the intersection of Houston's Grand Parkway (SH 99) and Southwest Freeway (US 59), the clinic provides a wide range of infusion therapy treatments to residents of Sugar Land, Richmond, Rosenberg, Missouri City, Stafford and the surrounding Fort Bend and greater Houston area.

AdaptIV Infusion partners with specialty physicians in neurology, gastroenterology, rheumatology, ophthalmology and immunology to offer FDA-approved infusion and injection therapies for a variety of chronic autoimmune disorders and other medical conditions. IV and injectable biologics, IVIG, antibiotics, vitamins/minerals and other specialty medications are professionally administered from the comfort of AdaptIV Infusion's state-of-the-art facility, which offers private and semi-private treatment areas, a community infusion room, a patient lounge with a fireplace, complimentary snacks and beverages, and a wide variety of entertainment options – from TVs and tablets to gaming consoles.

Using extensive qualitative research, we zeroed in on the specific features and amenities that would enhance our clients’ comfort during treatment, then designed a facility that offers an unparalleled patient experience.

Post this

AdaptIV Infusion's founders combine deep expertise across the health care, marketing, patient access and pharmaceutical industries, giving them a unique understanding of what patients want from a modern multi-specialty practice. "We surveyed hundreds of patients to learn precisely what they were looking for in their infusion care," explained Shareef Defrawi, AdaptIV Infusion CEO. "Using extensive qualitative research, we zeroed in on the specific features and amenities that would enhance our clients' comfort during treatment, then designed a facility that offers an unparalleled patient experience — from private suites to extra-large windows to zero-gravity massage chairs with warm blankets."

"It's a welcome change from the cold, sterile infusion facilities that most patients are used to," Defrawi continued. "Our research showed that everyone has a different definition of comfort, and we believe AdaptIV Infusion's facility delivers on all fronts."
AdaptIV Infusion's founders didn't just set out to reimagine the patient experience during treatment sessions; they also sought to both streamline and simplify the process of accessing care in the first place. "We know from personal and professional experience that patients and providers alike face an incredible administrative and financial burden when it comes to affordable, accessible, patient-centered treatment," said Aylin Poulton, AdaptIV Infusion Managing Partner. "We started AdaptIV Infusion to help take that burden off both patients and their referring physicians."

AdaptIV Infusion works closely with patients to access all available copay, foundation and financial assistance options, as well as handling benefit investigations and prior authorizations for treatment. "We accept almost every major commercial insurance plan, big and small," Poulton added, "and our team is committed to finding the most cost-effective solutions for our patients. This translates to significant savings on treatment for patients taking specialty medications when compared to the hospital setting. We're extremely proud to be removing barriers to best-in-class, affordable health care so our patients can access the treatments they need in a comfortable environment."

About AdaptIV Infusion

AdaptIV Infusion is an ambulatory infusion clinic providing intravenous and injection therapies of specialty drugs to patients suffering from autoimmune disorders and complex chronic conditions such as gout, Crohn's disease, multiple sclerosis, rheumatoid arthritis, thyroid eye disease, psoriasis and more.

AdaptIV Infusion is on a mission to reimagine infusion care with a relentless focus on the patient experience; providing best-in-class clinical care and affordable access to therapies in a comfortable setting, close to home and outside of the hospital environment.

Media Contact

Shareef Defrawi, AdaptIV Infusion, 832-895-5000, [email protected]

LinkedIn, Facebook

SOURCE AdaptIV Infusion

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.